The tweet was deleted by the author.
But we saved everything 🙂.
Altimmune is set to participate in EASL26 in Barcelona, connecting with the international liver disease community.
The company invites attendees to visit its Medical Affairs team at booth D-40 to learn more about ongoing initiatives and access a list of planned presentations. Altimmune aims to strengthen its position within the sector through active engagement at the event.
Altimmune has previously called for early intervention and research on the connection between alcohol use disorder and liver disease in a recent statement. The company also released its first quarter 2026 financial results, providing a snapshot of recent performance. These efforts come as Altimmune continues to engage with the liver disease community.